Roemeling et al. detected the overexpression of NPTX2 in ccRCC primary tumors and metastases, and showed that it promoted tumor cell viability and migration by interacting with the AMPA receptor subunit GluR4 [32]. This evidence concerns the gene NPTX2 and nonpapillary renal cell carcinoma.